On November 4, 2021, "Respiratory Research" under the famous British medical journal BMJ published a multi-center, randomized, double-blind, parallel controlled study (RCT) led by Academician Zhong Nanshan in ten famous domestic hospitals: "Hydrogen and oxygen inhalation therapy Generator acute onset of chronic obstructive pulmonary disease"

On November 5, 2021, Japan published a book "Hydrogen Immunotherapy: Letting Cancer Go away" by Junko Akagi. Professor Xu Kecheng said he was very happy, first because his "Hydrogen Control Cancer: Theory and Practice" is no longer "lonely"; second, he has also studied the immunomodulatory effect of hydrogen on lung cancer patients and found that PEM Hydrogen Inhalation Machine for 2 weeks can cause Active T lymphocytes rise, and depleted T cells fall. This article was published in "Med Gas Res" last year; thirdly, the author of this book is familiar with him. On June 1, 2019, Professor Xu Kecheng held a new book launch conference in Guangzhou, Akagi Juner once invited him to tell This is the result of his "hydrogen immunity" research.

In fact, Akagi also published an article on "Oncol Letter" last year, reporting the treatment results of 56 lung cancer patients with Hydrogen Inhalation Ventilator, showing that hydrogen can improve mitochondrial function and enhance the effect of anti-PD-1 drugs. It is likely that the author's new book is based on the above research. I saw several pictures of lung cancer in the "news" of this book, showing that the tumor lesions disappeared after hydrogen inhalation.

Preliminary practice has shown that hydrogen and oxygen inhalation seems to have "special" effects on lung cancer. I look forward to seeing RCT studies on hydrogen (hydrogen and oxygen) treatment of lung cancer in the near future.